The cancer–natural killer cell immunity cycle-Reference-Cited by-同舟云学术

The cancer–natural killer cell immunity cycle

Published:2020-06-24 Issue:8 Volume:20 Page:437-454
ISSN:1474-175X
Container-title:Nature Reviews Cancer
language:en
Short-container-title:Nat Rev Cancer

Author:

Huntington Nicholas D.^ORCID,Cursons Joseph^ORCID,Rautela Jai

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

http://www.nature.com/articles/s41568-020-0272-z.pdf

Reference192 articles.

1. Huntington, N. D., Vosshenrich, C. A. & Di Santo, J. P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7, 703–714 (2007).

2. Pfefferle, A. et al. Intra-lineage plasticity and functional reprogramming maintain natural killer cell repertoire diversity. Cell Rep. 29, 2284–2294 (2019).

3. Freud, A. G. & Caligiuri, M. A. Human natural killer cell development. Immunol. Rev. 214, 56–72 (2006).

4. Cursons, J. et al. A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients. Cancer Immunol. Res. 7, 1162–1174 (2019). This paper presents an in-depth analysis of NK cell gene expression in metastatic melanoma, defining a robust NK cell gene signature that can be applied to cancer transcriptomic datasets.

5. Lee, H. et al. Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients. Oncoimmunology 8, e1537581 (2019).

Cited by 363 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer;Biochemical and Biophysical Research Communications;2024-11

3. Role of tumor-derived exosomes mediated immune cell reprograming in cancer;Gene;2024-10

4. The stress response regulator HSF1 modulates natural killer cell anti-tumour immunity;Nature Cell Biology;2024-09-02

5. Developing oxaliplatin and IL-15 Co-carried gels as drug depots to enable triple-interlocked combination therapy for colorectal cancer;Colloids and Surfaces B: Biointerfaces;2024-09